Janssen turns to Danish startup for pill to replace the need to inject drugs
Danish biotech firm Biograil, founded by two former Egalet researchers, has entered a partnership with major pharmaceutical company Janssen and is poised to raise new capital.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
In the beginning of 2020, when MedWatch interviewed the people behind the young biotech firm Biograil, they indicated that they were looking for partners within the pharmaceutical industry. Now – just under a year later – they managed to poach the first one.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
